Pharma industry to be considered on drug price control: ASSOCHAM

Image
ANI New Delhi
Last Updated : Mar 10 2016 | 5:13 PM IST

The government will not take any decision on drug price control without holding discussions with the pharmaceutical industry and other stakeholders, Union Minister of State for Chemicals and Fertilisers, Hansraj Gangaram Ahir said at an ASSOCHAM event in Delhi.

"We take every step very carefully when it comes to the issue of drug price control as we do not want to take even a single step without holding discussions with the industry," said Ahir while inaugurating 'MEDCON 2016,' organized by ASSOCHAM.

He said that government wants the prices of medicines to be affordable for general public, but at the same it wants the industry to flourish. "We need to promote the industry for sure, this is certain."

The minister also said that the government will soon come out with a policy on medical devices.

Terming India as the 'medical store of the world,' the minister said that there are over 10,000 big and small drug manufacturing industries across the country. "We are exporting drugs into over 200 countries, it is a big achievement."

However, he said that it is concerning to note that over 5,000 industries engaged in drug manufacturing do not carry out research and development process, which is the need of the hour.

In his address at the ASSOCHAM event, Jagdish Prasad, Director General of Health Services said that with a view to perk up drug manufacturing standards in India, the government has asked drug manufacturers to set up research and development (Research and Development) system to ensure they follow quality standards.

"Drug manufacturers should either have a Research and Development system of their own or they should be attached to Research and Development, which is available in other industries, without Research and Development they should not manufacture drugs, we are trying to put this to drug manufacturers across the country to have high quality drugs available with them," said Prasad.

He also said that India has the potential to produce much better medical devices compared to those being manufactured in China.

"Most of the Chinese equipment used in medical system, be it monitors, ventilators and others, we can produce much better medical equipments compared to China," said Prasad.

"Today, India is totally dependent on medical devices imported either from China or from European countries, hardly any medical device is made for diagnostics set up which we can produce and export in the country," he added.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 10 2016 | 5:03 PM IST

Next Story